| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.85 | 0.004 | 0.85 | Aldehyde oxidase inhibitor | 0.799 0.004 DBMET00414 | ||
| 0.768 | 0.004 | 0.768 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.235 0.029 DBMET00414 | ||
| 0.641 | 0.004 | 0.641 | EphB2 antagonist | 0.424 0.014 DBMET00414 | ||
| 0.639 | 0.005 | 0.639 | Vascular endothelial growth factor antagonist | 0.114 0.072 DBMET00414 | ||
| 0.63 | 0.005 | 0.63 | Vascular endothelial growth factor 2 antagonist | 0.098 0.073 DBMET00414 | ||
| 0.616 | 0.004 | 0.616 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.162 0.042 DBMET00414 | ||
| 0.615 | 0.004 | 0.615 | Abl kinase inhibitor | 0.162 0.042 DBMET00414 | ||
| 0.614 | 0.005 | 0.614 | RET inhibitor | 0.242 0.033 DBMET00414 | ||
| 0.602 | 0.016 | 0.602 | Angiogenesis inhibitor | 0.25 0.123 DBMET00414 | ||
| 0.568 | 0.003 | 0.568 | Xanthine oxidase inhibitor | 0.449 0.004 DBMET00414 | ||
| 0.575 | 0.012 | 0.575 | Tyrosine kinase inhibitor | |||
| 0.556 | 0.005 | 0.556 | TRKC antagonist | 0.496 0.006 DBMET00414 | ||
| 0.538 | 0.003 | 0.538 | Ribosomal protein S6 kinase inhibitor | 0.418 0.005 DBMET00414 | ||
| 0.505 | 0.011 | 0.505 | Growth factor antagonist | |||
| 0.496 | 0.006 | 0.496 | Src kinase inhibitor | 0.128 0.101 DBMET00414 | ||
| 0.492 | 0.004 | 0.492 | Protein-tyrosine kinase Lyn inhibitor | 0.206 0.044 DBMET00414 | ||
| 0.485 | 0.005 | 0.485 | c-Src kinase inhibitor | 0.131 0.067 DBMET00414 | ||
| 0.486 | 0.014 | 0.486 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.304 0.049 DBMET00414 | ||
| 0.491 | 0.028 | 0.491 | GABA C receptor rho-3 antagonist | 0.447 0.043 DBMET00414 | ||
| 0.47 | 0.016 | 0.47 | DNA synthesis inhibitor | 0.415 0.02 DBMET00414 | ||
| 0.47 | 0.017 | 0.47 | Dyrk kinase inhibitor | 0.294 0.055 DBMET00414 | ||
| 0.481 | 0.039 | 0.481 | 5 Hydroxytryptamine release inhibitor | 0.405 0.075 DBMET00414 | ||
| 0.466 | 0.028 | 0.466 | MAP kinase kinase 6 inhibitor | 0.393 0.063 DBMET00414 | ||
| 0.426 | 0.009 | 0.426 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.155 0.126 DBMET00414 | ||
| 0.422 | 0.015 | 0.458 | Clk dual-specificity kinase inhibitor | 0.458 0.01 DBMET00414 | DBMET00414 | |
| 0.416 | 0.013 | 0.482 | CDC-like kinase 4 inhibitor | 0.482 0.008 DBMET00414 | DBMET00414 | |
| 0.469 | 0.067 | 0.469 | MAP kinase 1 inhibitor | 0.444 0.081 DBMET00414 | ||
| 0.404 | 0.013 | 0.404 | CDC-like kinase 2 inhibitor | 0.222 0.056 DBMET00414 | ||
| 0.397 | 0.008 | 0.397 | Lck kinase inhibitor | |||
| 0.391 | 0.012 | 0.391 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.236 0.053 DBMET00414 | ||
| 0.379 | 0.003 | 0.379 | Death-associated protein kinase 1 inhibitor | 0.197 0.008 DBMET00414 | ||
| 0.38 | 0.005 | 0.38 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.313 0.008 DBMET00414 | ||
| 0.373 | 0.005 | 0.373 | Platelet activating factor alpha antagonist | |||
| 0.368 | 0.007 | 0.368 | Cyclin-dependent kinase 1 inhibitor | 0.226 0.022 DBMET00414 | ||
| 0.368 | 0.01 | 0.49 | Glycogen synthase kinase-3 inhibitor | 0.49 0.005 DBMET00414 | DBMET00414 | |
| 0.359 | 0.009 | 0.467 | Glycogen synthase kinase-3 alpha inhibitor | 0.467 0.005 DBMET00414 | DBMET00414 | |
| 0.36 | 0.024 | 0.36 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.283 0.037 DBMET00414 | ||
| 0.34 | 0.012 | 0.34 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.133 0.072 DBMET00414 | ||
| 0.333 | 0.005 | 0.366 | Rho-associated kinase II inhibitor | 0.366 0.005 DBMET00414 | DBMET00414 | |
| 0.324 | 0.004 | 0.324 | Protein kinase C delta inhibitor | 0.251 0.005 DBMET00414 | ||
| 0.334 | 0.015 | 0.334 | MAP-kinase-activated kinase 5 inhibitor | 0.308 0.026 DBMET00414 | ||
| 0.331 | 0.019 | 0.331 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.316 0.022 DBMET00414 | ||
| 0.319 | 0.009 | 0.319 | Platelet activating factor antagonist | |||
| 0.324 | 0.016 | 0.324 | LIM domain kinase 1 inhibitor | 0.284 0.025 DBMET00414 | ||
| 0.317 | 0.009 | 0.317 | M17 leucyl aminopeptidase inhibitor | |||
| 0.311 | 0.01 | 0.311 | Vascular endothelial growth factor 1 antagonist | 0.134 0.047 DBMET00414 | ||
| 0.312 | 0.013 | 0.457 | Glycogen synthase kinase-3 beta inhibitor | 0.457 0.005 DBMET00414 | DBMET00414 | |
| 0.301 | 0.004 | 0.301 | Protein kinase C alpha inhibitor | 0.263 0.004 DBMET00414 | ||
| 0.3 | 0.004 | 0.3 | Protein kinase B alpha inhibitor | 0.109 0.025 DBMET00414 | ||
| 0.326 | 0.03 | 0.326 | Platelet aggregation inhibitor | |||
| 0.324 | 0.03 | 0.349 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.349 0.023 DBMET00414 | DBMET00414 | |
| 0.299 | 0.005 | 0.299 | Raf kinase B inhibitor | 0.219 0.008 DBMET00414 | ||
| 0.322 | 0.032 | 0.322 | Death-associated protein kinase 3 inhibitor | 0.284 0.042 DBMET00414 | ||
| 0.3 | 0.011 | 0.3 | Protein kinase (CK2) alpha inhibitor | 0.129 0.056 DBMET00414 | ||
| 0.299 | 0.011 | 0.299 | Platelet activating factor beta antagonist | |||
| 0.293 | 0.011 | 0.293 | TRKB antagonist | 0.148 0.048 DBMET00414 | ||
| 0.311 | 0.03 | 0.311 | RNA-directed DNA polymerase inhibitor | 0.239 0.057 DBMET00414 | ||
| 0.286 | 0.007 | 0.286 | Raf kinase inhibitor | 0.202 0.012 DBMET00414 | ||
| 0.295 | 0.025 | 0.295 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.274 | 0.005 | 0.407 | Uric acid excretion stimulant | 0.407 0.004 DBMET00414 | DBMET00414 | |
| 0.301 | 0.035 | 0.301 | MAP kinase kinase 2 inhibitor | 0.218 0.071 DBMET00414 | ||
| 0.286 | 0.021 | 0.286 | Vascular endothelial growth factor 3 antagonist | 0.13 0.084 DBMET00414 | ||
| 0.278 | 0.013 | 0.278 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.285 | 0.022 | 0.285 | Cyclin-dependent kinase inhibitor | 0.258 0.026 DBMET00414 | ||
| 0.292 | 0.029 | 0.299 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.299 0.025 DBMET00414 | DBMET00414 | |
| 0.267 | 0.006 | 0.267 | Polo-like kinase-4 inhibitor | 0.234 0.01 DBMET00414 | ||
| 0.264 | 0.005 | 0.264 | MAP kinase kinase 4 inhibitor | 0.166 0.037 DBMET00414 | ||
| 0.268 | 0.008 | 0.268 | Fibroblast growth factor 1 antagonist | 0.121 0.043 DBMET00414 | ||
| 0.352 | 0.099 | 0.387 | Histamine release inhibitor | 0.387 0.082 DBMET00414 | DBMET00414 | |
| 0.292 | 0.039 | 0.292 | Peroxidase inhibitor | 0.17 0.069 DBMET00414 | ||
| 0.26 | 0.008 | 0.26 | Protein kinase A inhibitor | 0.22 0.011 DBMET00414 | ||
| 0.286 | 0.037 | 0.286 | ErbB-1 antagonist | |||
| 0.252 | 0.004 | 0.252 | Xanthine dehydrogenase inhibitor | 0.202 0.004 DBMET00414 | ||
| 0.256 | 0.01 | 0.256 | TIE antagonist | |||
| 0.257 | 0.014 | 0.257 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.252 | 0.01 | 0.252 | TIE-2 antagonist | |||
| 0.37 | 0.129 | 0.419 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.419 0.084 DBMET00414 | DBMET00414 | |
| 0.26 | 0.019 | 0.26 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.256 | 0.015 | 0.256 | Cyclin-dependent kinase 3 inhibitor | 0.248 0.016 DBMET00414 | ||
| 0.248 | 0.008 | 0.287 | Rho-associated kinase inhibitor | 0.287 0.006 DBMET00414 | DBMET00414 | |
| 0.249 | 0.014 | 0.249 | GABA C receptor agonist | 0.115 0.053 DBMET00414 | ||
| 0.246 | 0.012 | 0.246 | Protein kinase (CK2) inhibitor | 0.243 0.012 DBMET00414 | ||
| 0.273 | 0.04 | 0.301 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.301 0.031 DBMET00414 | DBMET00414 | |
| 0.245 | 0.015 | 0.245 | Ephrin antagonist | |||
| 0.247 | 0.018 | 0.372 | Aurora-A kinase inhibitor | 0.372 0.008 DBMET00414 | DBMET00414 | |
| 0.23 | 0.006 | 0.23 | Protein kinase B gamma inhibitor | 0.175 0.01 DBMET00414 | ||
| 0.235 | 0.018 | 0.235 | MAP kinase kinase inhibitor | 0.127 0.067 DBMET00414 | ||
| 0.252 | 0.036 | 0.252 | I kappa B kinase epsilon inhibitor | 0.183 0.086 DBMET00414 | ||
| 0.239 | 0.025 | 0.485 | Phosphodiesterase inhibitor | 0.485 0.005 DBMET00414 | DBMET00414 | |
| 0.267 | 0.055 | 0.41 | Cyclic AMP phosphodiesterase inhibitor | 0.41 0.015 DBMET00414 | DBMET00414 | |
| 0.206 | 0.005 | 0.206 | Protein kinase B beta inhibitor | 0.16 0.006 DBMET00414 | ||
| 0.206 | 0.005 | 0.206 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.118 0.026 DBMET00414 | ||
| 0.232 | 0.031 | 0.232 | Tyrosine-protein kinase receptor antagonist | 0.138 0.071 DBMET00414 | ||
| 0.224 | 0.023 | 0.244 | Cyclin-dependent kinase 8 inhibitor | 0.244 0.017 DBMET00414 | DBMET00414 | |
| 0.318 | 0.119 | 0.318 | 15-Lipoxygenase inhibitor | |||
| 0.206 | 0.009 | 0.206 | MAP kinase 10 inhibitor | 0.097 0.037 DBMET00414 | ||
| 0.214 | 0.02 | 0.256 | Cyclin-dependent kinase 5 inhibitor | 0.256 0.014 DBMET00414 | DBMET00414 | |
| 0.199 | 0.007 | 0.207 | CDK3/cyclin E inhibitor | 0.207 0.005 DBMET00414 | DBMET00414 | |
| 0.194 | 0.007 | 0.194 | MAP3K7 inhibitor | |||
| 0.22 | 0.034 | 0.22 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.174 0.056 DBMET00414 | ||
| 0.206 | 0.021 | 0.206 | MAP kinase 9 inhibitor | 0.097 0.065 DBMET00414 | ||
| 0.205 | 0.021 | 0.205 | MAP kinase 3 inhibitor | 0.16 0.054 DBMET00414 | ||
| 0.203 | 0.024 | 0.254 | Cyclin-dependent kinase 2 inhibitor | 0.254 0.017 DBMET00414 | DBMET00414 | |
| 0.191 | 0.021 | 0.191 | MAP kinase kinase kinase inhibitor | 0.102 0.065 DBMET00414 | ||
| 0.179 | 0.018 | 0.179 | Adenylate kinase inhibitor | 0.095 0.076 DBMET00414 | ||
| 0.172 | 0.012 | 0.172 | Phosphodiesterase 3A inhibitor | 0.118 0.023 DBMET00414 | ||
| 0.171 | 0.014 | 0.171 | ErbB-2 antagonist | |||
| 0.168 | 0.011 | 0.168 | Adenosine A3 receptor antagonist | 0.091 0.032 DBMET00414 | ||
| 0.198 | 0.043 | 0.198 | Protein kinase (CK1) gamma 1 inhibitor | 0.149 0.069 DBMET00414 | ||
| 0.209 | 0.055 | 0.209 | Growth factor agonist | |||
| 0.163 | 0.01 | 0.163 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.171 | 0.021 | 0.171 | GABA C receptor antagonist | 0.111 0.062 DBMET00414 | ||
| 0.157 | 0.008 | 0.157 | NMDA 2B receptor antagonist | 0.08 0.021 DBMET00414 | ||
| 0.165 | 0.018 | 0.165 | Hepatocyte growth factor antagonist | 0.085 0.069 DBMET00414 | ||
| 0.19 | 0.044 | 0.287 | Protein kinase (CK1) inhibitor | 0.287 0.019 DBMET00414 | DBMET00414 | |
| 0.16 | 0.015 | 0.194 | Phosphodiesterase I inhibitor | 0.194 0.011 DBMET00414 | DBMET00414 | |
| 0.179 | 0.034 | 0.179 | Glutamate receptor antagonist | |||
| 0.163 | 0.02 | 0.163 | Epidermal growth factor antagonist | |||
| 0.155 | 0.014 | 0.538 | Check point kinase 1 inhibitor | 0.538 0.004 DBMET00414 | DBMET00414 | |
| 0.182 | 0.041 | 0.182 | Mannose-6-phosphate isomerase inhibitor | 0.137 0.077 DBMET00414 | ||
| 0.146 | 0.007 | 0.146 | Phosphodiesterase 1B inhibitor | 0.098 0.015 DBMET00414 | ||
| 0.187 | 0.049 | 0.295 | Protein kinase (CK1) gamma inhibitor | 0.295 0.019 DBMET00414 | DBMET00414 | |
| 0.156 | 0.019 | 0.573 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.573 0.004 DBMET00414 | DBMET00414 | |
| 0.146 | 0.011 | 0.146 | Cyclin E inhibitor | 0.13 0.014 DBMET00414 | ||
| 0.171 | 0.037 | 0.171 | Aldehyde dehydrogenase inhibitor | |||
| 0.161 | 0.027 | 0.161 | CDK/cyclin complex inhibitor | 0.109 0.047 DBMET00414 | ||
| 0.136 | 0.002 | 0.136 | Alpha 1d adrenoreceptor agonist | 0.067 0.008 DBMET00414 | ||
| 0.245 | 0.113 | 0.245 | Nootropic | |||
| 0.155 | 0.024 | 0.155 | CDK2/cyclin A inhibitor | 0.11 0.05 DBMET00414 | ||
| 0.147 | 0.016 | 0.147 | CDK1/cyclin B1 inhibitor | 0.069 0.049 DBMET00414 | ||
| 0.157 | 0.027 | 0.157 | MAP kinase 8 inhibitor | 0.106 0.054 DBMET00414 | ||
| 0.211 | 0.082 | 0.245 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.245 0.063 DBMET00414 | DBMET00414 | |
| 0.166 | 0.044 | 0.166 | Protein kinase (CK1) delta inhibitor | 0.138 0.061 DBMET00414 | ||
| 0.173 | 0.051 | 0.173 | Activin receptor-like kinase 2 inhibitor | 0.153 0.064 DBMET00414 | ||
| 0.182 | 0.061 | 0.182 | Heat shock protein 90 alpha antagonist | |||
| 0.173 | 0.053 | 0.173 | CDC-like kinase 1 inhibitor | |||
| 0.195 | 0.077 | 0.195 | Histone acetyltransferase inhibitor | 0.169 0.115 DBMET00414 | ||
| 0.138 | 0.021 | 0.138 | NADH dehydrogenase inhibitor | 0.099 0.045 DBMET00414 | ||
| 0.128 | 0.01 | 0.128 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.024 DBMET00414 | ||
| 0.168 | 0.052 | 0.168 | GABA C receptor rho-2 antagonist | 0.168 0.053 DBMET00414 | ||
| 0.178 | 0.062 | 0.185 | Protein kinase (CK1) gamma 3 inhibitor | 0.185 0.057 DBMET00414 | DBMET00414 | |
| 0.132 | 0.016 | 0.132 | CDK1/cyclin B inhibitor | 0.061 0.045 DBMET00414 | ||
| 0.172 | 0.056 | 0.172 | Hexokinase inhibitor | 0.131 0.102 DBMET00414 | ||
| 0.12 | 0.005 | 0.128 | Protein kinase C theta inhibitor | 0.128 0.005 DBMET00414 | DBMET00414 | |
| 0.14 | 0.025 | 0.14 | Insulin growth factor antagonist | |||
| 0.138 | 0.025 | 0.138 | Alcohol dehydrogenase inhibitor | 0.115 0.039 DBMET00414 | ||
| 0.192 | 0.08 | 0.289 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.289 0.046 DBMET00414 | DBMET00414 | |
| 0.124 | 0.016 | 0.124 | Fibroblast growth factor 2 antagonist | |||
| 0.163 | 0.056 | 0.163 | CF transmembrane conductance regulator agonist | 0.127 0.125 DBMET00414 | ||
| 0.141 | 0.035 | 0.141 | Check point kinase 2 inhibitor | 0.123 0.047 DBMET00414 | ||
| 0.14 | 0.034 | 0.14 | Activin receptor-like kinase 4 inhibitor | 0.107 0.072 DBMET00414 | ||
| 0.131 | 0.026 | 0.131 | MAP kinase kinase 1 inhibitor | |||
| 0.128 | 0.023 | 0.128 | Bcr-Abl kinase inhibitor | |||
| 0.129 | 0.026 | 0.129 | Insulin like growth factor 1 antagonist | |||
| 0.159 | 0.057 | 0.159 | Cell wall synthesis inhibitor | |||
| 0.123 | 0.022 | 0.123 | CDK2/cyclin E2 inhibitor | 0.122 0.022 DBMET00414 | ||
| 0.206 | 0.106 | 0.206 | MAP kinase kinase 3 inhibitor | 0.203 0.114 DBMET00414 | ||
| 0.22 | 0.121 | 0.22 | Streptokinase A inhibitor | |||
| 0.106 | 0.009 | 0.106 | MAP kinase kinase 7 inhibitor | |||
| 0.146 | 0.052 | 0.146 | TRKA antagonist | 0.106 0.082 DBMET00414 | ||
| 0.122 | 0.028 | 0.122 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.158 | 0.065 | 0.355 | Protein kinase C nu inhibitor | 0.355 0.015 DBMET00414 | DBMET00414 | |
| 0.109 | 0.018 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.048 DBMET00414 | ||
| 0.112 | 0.022 | 0.112 | Raf kinase C inhibitor | |||
| 0.101 | 0.013 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.097 | 0.011 | 0.106 | Phosphodiesterase 1C inhibitor | 0.106 0.009 DBMET00414 | DBMET00414 | |
| 0.129 | 0.046 | 0.129 | EphA2 antagonist | |||
| 0.178 | 0.095 | 0.178 | DNA methylase inhibitor | |||
| 0.099 | 0.017 | 0.099 | Purinergic P2X1 antagonist | |||
| 0.134 | 0.054 | 0.139 | Aurora-B kinase inhibitor | 0.139 0.051 DBMET00414 | DBMET00414 | |
| 0.102 | 0.023 | 0.102 | Adenosine A1 receptor antagonist | 0.078 0.029 DBMET00414 | ||
| 0.101 | 0.023 | 0.101 | Cyclin A inhibitor | |||
| 0.102 | 0.024 | 0.102 | Cyclin A2 inhibitor | |||
| 0.098 | 0.02 | 0.098 | Cyclin E1 inhibitor | 0.087 0.022 DBMET00414 | ||
| 0.112 | 0.036 | 0.112 | Leucine-rich repeat kinase 2 inhibitor | 0.085 0.053 DBMET00414 | ||
| 0.092 | 0.017 | 0.092 | Bruton tyrosine kinase inhibitor | |||
| 0.15 | 0.076 | 0.15 | Cytidine deaminase inhibitor | 0.121 0.1 DBMET00414 | ||
| 0.149 | 0.076 | 0.149 | Heat shock protein 90 antagonist | |||
| 0.091 | 0.021 | 0.091 | Biliverdin reductase inhibitor | 0.08 0.026 DBMET00414 | ||
| 0.106 | 0.037 | 0.106 | ErbB-4 antagonist | |||
| 0.116 | 0.048 | 0.116 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.1 | 0.032 | 0.1 | mTOR complex 2 inhibitor | 0.083 0.061 DBMET00414 | ||
| 0.095 | 0.027 | 0.095 | CDC7 inhibitor | 0.087 0.031 DBMET00414 | ||
| 0.134 | 0.066 | 0.134 | Alpha-N-acetylglucosaminidase inhibitor | 0.112 0.086 DBMET00414 | ||
| 0.083 | 0.015 | 0.117 | Phosphodiesterase 1A inhibitor | 0.117 0.007 DBMET00414 | DBMET00414 | |
| 0.141 | 0.074 | 0.209 | MAP3K9 inhibitor | 0.209 0.012 DBMET00414 | DBMET00414 | |
| 0.128 | 0.06 | 0.204 | MAP kinase 12 inhibitor | 0.204 0.021 DBMET00414 | DBMET00414 | |
| 0.076 | 0.009 | 0.076 | Alpha 1b adrenoreceptor agonist | |||
| 0.096 | 0.028 | 0.096 | Adenosine A2 receptor antagonist | 0.078 0.036 DBMET00414 | ||
| 0.084 | 0.018 | 0.084 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.113 | 0.047 | 0.113 | Insulin receptor antagonist | |||
| 0.084 | 0.018 | 0.084 | Heat shock protein 90 beta antagonist | |||
| 0.098 | 0.034 | 0.098 | Fibroblast growth factor 3 antagonist | |||
| 0.097 | 0.033 | 0.097 | Rho-associated kinase I inhibitor | 0.09 0.038 DBMET00414 | ||
| 0.103 | 0.042 | 0.103 | Stem cell growth factor agonist | |||
| 0.086 | 0.025 | 0.086 | Phosphatidylinositol kinase inhibitor | |||
| 0.181 | 0.121 | 0.434 | Vasodilator | 0.434 0.018 DBMET00414 | DBMET00414 | |
| 0.11 | 0.05 | 0.11 | GABA C receptor rho-1 antagonist | 0.097 0.067 DBMET00414 | ||
| 0.103 | 0.043 | 0.103 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.14 | 0.081 | 0.14 | Hemostatic | |||
| 0.102 | 0.043 | 0.179 | Pim-3 kinase inhibitor | 0.179 0.011 DBMET00414 | DBMET00414 | |
| 0.071 | 0.013 | 0.071 | Adenosine deaminase inhibitor | |||
| 0.082 | 0.024 | 0.082 | TRPA1 antagonist | 0.067 0.035 DBMET00414 | ||
| 0.084 | 0.026 | 0.135 | MAP kinase kinase 10 inhibitor | 0.135 0.012 DBMET00414 | DBMET00414 | |
| 0.062 | 0.003 | 0.112 | Phosphodiesterase 9A inhibitor | 0.112 0.002 DBMET00414 | DBMET00414 | |
| 0.061 | 0.003 | 0.061 | Egl nine homolog 2 inhibitor | |||
| 0.08 | 0.022 | 0.08 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.08 | 0.023 | 0.08 | EphB4 antagonist | |||
| 0.204 | 0.147 | 0.204 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.156 | 0.101 | 0.156 | Succinate dehydrogenase inhibitor | |||
| 0.059 | 0.004 | 0.14 | Phosphodiesterase IX inhibitor | 0.14 0.002 DBMET00414 | DBMET00414 | |
| 0.08 | 0.025 | 0.08 | Exportin-1 inhibitor | |||
| 0.09 | 0.036 | 0.09 | Phosphofructokinase-1 inhibitor | |||
| 0.114 | 0.062 | 0.114 | MAP kinase 13 inhibitor | 0.112 0.064 DBMET00414 | ||
| 0.065 | 0.013 | 0.065 | DNA-dependent protein kinase inhibitor | |||
| 0.162 | 0.112 | 0.162 | Focal adhesion kinase 2 inhibitor | |||
| 0.103 | 0.056 | 0.103 | Creatine kinase inhibitor | |||
| 0.069 | 0.022 | 0.069 | mTOR inhibitor | 0.056 0.032 DBMET00414 | ||
| 0.173 | 0.126 | 0.173 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.085 | 0.04 | 0.085 | Glutamate dehydrogenase inhibitor | |||
| 0.119 | 0.074 | 0.177 | DNA repair enzyme inhibitor | 0.177 0.014 DBMET00414 | DBMET00414 | |
| 0.102 | 0.058 | 0.175 | UDP-glucose 4-epimerase inhibitor | 0.175 0.022 DBMET00414 | DBMET00414 | |
| 0.068 | 0.024 | 0.068 | Cyclin B inhibitor | |||
| 0.15 | 0.107 | 0.157 | Death-associated protein kinase 2 inhibitor | 0.157 0.092 DBMET00414 | DBMET00414 | |
| 0.068 | 0.026 | 0.068 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.05 | 0.009 | 0.05 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.048 0.01 DBMET00414 | ||
| 0.047 | 0.005 | 0.047 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.147 | 0.107 | 0.147 | DNA methyltransferase I inhibitor | |||
| 0.067 | 0.027 | 0.068 | Cyclin A1 inhibitor | 0.068 0.024 DBMET00414 | DBMET00414 | |
| 0.043 | 0.004 | 0.045 | DNA polymerase III inhibitor | 0.045 0.004 DBMET00414 | DBMET00414 | |
| 0.083 | 0.045 | 0.083 | Porphobilinogen synthase inhibitor | |||
| 0.079 | 0.041 | 0.079 | Syk tyrosine kinase inhibitor | |||
| 0.087 | 0.051 | 0.087 | ALK inhibitor | |||
| 0.049 | 0.013 | 0.049 | MAP3K5 inhibitor | |||
| 0.11 | 0.074 | 0.249 | Protein kinase (CK1) gamma 2 inhibitor | 0.249 0.021 DBMET00414 | DBMET00414 | |
| 0.041 | 0.006 | 0.125 | Thymidine phosphorylase inhibitor | 0.125 0.002 DBMET00414 | DBMET00414 | |
| 0.134 | 0.099 | 0.134 | Ca2+-transporting ATPase inhibitor | |||
| 0.052 | 0.017 | 0.052 | Thymidine kinase inhibitor | 0.049 0.019 DBMET00414 | ||
| 0.104 | 0.07 | 0.107 | Protein kinase C gamma inhibitor | 0.107 0.066 DBMET00414 | DBMET00414 | |
| 0.062 | 0.029 | 0.062 | Cyclin B2 inhibitor | |||
| 0.085 | 0.054 | 0.085 | AXL receptor tyrosine kinase inhibitor | |||
| 0.057 | 0.026 | 0.088 | Adenosine A2b receptor antagonist | 0.088 0.012 DBMET00414 | DBMET00414 | |
| 0.038 | 0.008 | 0.038 | Purinergic P2Y15 antagonist | |||
| 0.063 | 0.033 | 0.063 | Alcohol oxidase inhibitor | |||
| 0.116 | 0.087 | 0.302 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.302 0.018 DBMET00414 | DBMET00414 | |
| 0.173 | 0.144 | 0.173 | Nitric-oxide synthase stimulant | 0.17 0.151 DBMET00414 | ||
| 0.039 | 0.01 | 0.039 | LIM domain kinase 2 inhibitor | |||
| 0.118 | 0.089 | 0.118 | Alkaline phosphatase inhibitor | |||
| 0.076 | 0.048 | 0.076 | Polo-like kinase-2 inhibitor | |||
| 0.063 | 0.035 | 0.063 | Argininosuccinate synthase inhibitor | 0.051 0.045 DBMET00414 | ||
| 0.05 | 0.023 | 0.05 | Geranyltranstransferase inhibitor | |||
| 0.061 | 0.034 | 0.075 | Fatty acid synthase inhibitor | 0.075 0.021 DBMET00414 | DBMET00414 | |
| 0.071 | 0.045 | 0.08 | Protein kinase C beta inhibitor | 0.08 0.03 DBMET00414 | DBMET00414 | |
| 0.03 | 0.003 | 0.03 | Egl nine homolog 3 inhibitor | |||
| 0.123 | 0.098 | 0.123 | Aurora-C kinase inhibitor | |||
| 0.034 | 0.009 | 0.034 | Adenosine kinase inhibitor | |||
| 0.028 | 0.004 | 0.028 | Egl nine homolog 1 inhibitor | |||
| 0.062 | 0.041 | 0.062 | Cyclin B1 inhibitor | |||
| 0.029 | 0.009 | 0.029 | Bombesin agonist | |||
| 0.056 | 0.037 | 0.076 | Bombesin 3 receptor antagonist | 0.076 0.021 DBMET00414 | DBMET00414 | |
| 0.046 | 0.029 | 0.063 | Phosphodiesterase 3B inhibitor | 0.063 0.018 DBMET00414 | DBMET00414 | |
| 0.049 | 0.032 | 0.058 | Antimetabolite | 0.058 0.027 DBMET00414 | DBMET00414 | |
| 0.041 | 0.024 | 0.041 | CF transmembrane conductance regulator antagonist | |||
| 0.065 | 0.048 | 0.423 | Phosphodiesterase III inhibitor | 0.423 0.004 DBMET00414 | DBMET00414 | |
| 0.025 | 0.008 | 0.025 | Bombesin 3 receptor agonist | |||
| 0.066 | 0.051 | 0.066 | MAP kinase kinase 8 inhibitor | |||
| 0.06 | 0.045 | 0.06 | Adenosine A2a receptor antagonist | |||
| 0.059 | 0.044 | 0.059 | CDK2/cyclin E inhibitor | |||
| 0.052 | 0.038 | 0.052 | GABA A receptor antagonist | |||
| 0.201 | 0.186 | 0.201 | Sodium/bile acid cotransporter inhibitor | |||
| 0.085 | 0.071 | 0.113 | Polo-like kinase-1 inhibitor | 0.113 0.034 DBMET00414 | DBMET00414 | |
| 0.126 | 0.115 | 0.23 | Polo-like kinase-3 inhibitor | 0.23 0.031 DBMET00414 | DBMET00414 | |
| 0.016 | 0.004 | 0.016 | Purine nucleoside phosphorylase inhibitor | |||
| 0.052 | 0.041 | 0.052 | GABA receptor antagonist | |||
| 0.015 | 0.005 | 0.015 | Glucose-dependent insulinotropic receptor antagonist | |||
| 0.087 | 0.08 | 0.089 | Electrolyte absorption antagonist | 0.089 0.076 DBMET00414 | DBMET00414 | |
| 0.037 | 0.031 | 0.037 | Dihydropteroate synthase inhibitor | |||
| 0.034 | 0.028 | 0.103 | Nicotinic acid receptor agonist | 0.103 0.005 DBMET00414 | DBMET00414 | |
| 0.045 | 0.04 | 0.045 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.05 | 0.045 | 0.05 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.051 | 0.048 | 0.051 | Glutamate (mGluR1) antagonist | |||
| 0.04 | 0.038 | 0.044 | AICAR transformylase inhibitor | 0.044 0.03 DBMET00414 | DBMET00414 | |
| 0.049 | 0.047 | 0.049 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.03 | 0.029 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.025 | 0.024 | 0.034 | Cyclin E2 inhibitor | 0.034 0.015 DBMET00414 | DBMET00414 | |
| 0.01 | 0.01 | 0.011 | CD80 antagonist | 0.011 0.008 DBMET00414 | DBMET00414 | |
| 0.178 | 0.182 | 0.18 | Tyrosine 3 hydroxylase inhibitor | 0.18 0.176 DBMET00414 | DBMET00414 | |
| 0.084 | 0.094 | 0.141 | Granulocyte macrophage colony stimulating factor antagonist | 0.141 0.04 DBMET00414 | DBMET00414 | |
| 0.057 | 0.067 | 0.081 | NMDA 2 receptor antagonist | 0.081 0.043 DBMET00414 | DBMET00414 | |
| 0.028 | 0.04 | 0.058 | Protein kinase (CK2) beta inhibitor | 0.058 0.005 DBMET00414 | DBMET00414 | |
| 0.031 | 0.045 | 0.046 | CDK5/p25 inhibitor | 0.046 0.024 DBMET00414 | DBMET00414 | |
| 0.029 | 0.044 | 0.104 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.104 0.006 DBMET00414 | DBMET00414 | |
| 0.055 | 0.071 | 0.063 | MAP kinase 14 inhibitor | 0.063 0.062 DBMET00414 | DBMET00414 | |
| 0.073 | 0.092 | 0.149 | Pim-1 kinase inhibitor | 0.149 0.028 DBMET00414 | DBMET00414 | |
| 0.026 | 0.046 | 0.041 | Protein kinase C beta II inhibitor | 0.041 0.01 DBMET00414 | DBMET00414 | |
| 0.035 | 0.059 | 0.125 | Poly(ADP-ribose) polymerase inhibitor | 0.125 0.006 DBMET00414 | DBMET00414 | |
| 0.021 | 0.051 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.022 DBMET00414 | DBMET00414 | |
| 0.075 | 0.107 | 0.114 | Ferrochelatase inhibitor | 0.114 0.058 DBMET00414 | DBMET00414 | |
| 0.003 | 0.042 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET00414 | DBMET00414 | |
| 0.016 | 0.056 | 0.069 | Nicotinic acid receptor 2 antagonist | 0.069 0.003 DBMET00414 | DBMET00414 | |
| 0.07 | 0.111 | 0.143 | Phosphodiesterase 7B inhibitor | 0.143 0.024 DBMET00414 | DBMET00414 | |
| 0.01 | 0.065 | 0.095 | Calcitonin gene-related peptide antagonist | 0.095 0.003 DBMET00414 | DBMET00414 | |
| 0.034 | 0.089 | 0.052 | Pim-2 kinase inhibitor | 0.052 0.042 DBMET00414 | DBMET00414 | |
| 0.025 | 0.081 | 0.043 | Thymidylate synthase inhibitor | 0.043 0.038 DBMET00414 | DBMET00414 | |
| 0.16 | 0.216 | 0.3 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.3 0.064 DBMET00414 | DBMET00414 | |
| 0.009 | 0.067 | 0.017 | Acetyl-CoA carboxylase 1 inhibitor | 0.017 0.014 DBMET00414 | DBMET00414 | |
| 0.069 | 0.128 | 0.202 | 5 Hydroxytryptamine 3A agonist | 0.202 0.014 DBMET00414 | DBMET00414 | |
| 0.024 | 0.084 | 0.054 | Nicotinic acid receptor 1 agonist | 0.054 0.018 DBMET00414 | DBMET00414 | |
| 0.01 | 0.079 | 0.029 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.029 0.019 DBMET00414 | DBMET00414 | |
| 0.01 | 0.08 | 0.042 | Uridine phosphorylase inhibitor | 0.042 0.011 DBMET00414 | DBMET00414 | |
| 0.036 | 0.116 | 0.077 | Dihydroorotate oxidase inhibitor | 0.077 0.012 DBMET00414 | DBMET00414 | |
| 0.014 | 0.097 | 0.128 | Nicotinic acid receptor 2 agonist | 0.128 0.005 DBMET00414 | DBMET00414 | |
| 0.015 | 0.101 | 0.041 | Urate transporter 1 inhibitor | 0.041 0.025 DBMET00414 | DBMET00414 | |
| 0.032 | 0.12 | 0.061 | Cyclin D1 inhibitor | 0.061 0.04 DBMET00414 | DBMET00414 | |
| 0.131 | 0.224 | 0.169 | Superoxide dismutase inhibitor | 0.169 0.157 DBMET00414 | DBMET00414 | |
| 0.007 | 0.108 | 0.127 | Calcitonin gene-related peptide 1 receptor antagonist | 0.127 0.003 DBMET00414 | DBMET00414 | |
| 0.05 | 0.162 | 0.09 | Protein kinase C mu inhibitor | 0.09 0.067 DBMET00414 | DBMET00414 | |
| 0.031 | 0.149 | 0.061 | Antiviral (Hepatitis D) | 0.061 0.021 DBMET00414 | DBMET00414 | |
| 0.047 | 0.17 | 0.127 | Bronchodilator | 0.127 0.041 DBMET00414 | DBMET00414 | |
| 0.103 | 0.231 | 0.14 | ATPase inhibitor | 0.14 0.12 DBMET00414 | DBMET00414 | |
| 0.196 | 0.339 | 0.271 | Antiinflammatory | 0.271 0.244 DBMET00414 | DBMET00414 | |
| 0.052 | 0.195 | 0.118 | Bromodomain-containing protein 2 inhibitor | 0.118 0.024 DBMET00414 | DBMET00414 | |
| 0.088 | 0.236 | 0.14 | Tumour necrosis factor antagonist | 0.14 0.113 DBMET00414 | DBMET00414 | |
| 0.155 | 0.351 | 0.235 | Cyclophilin D inhibitor | 0.235 0.23 DBMET00414 | DBMET00414 | |
| 0.043 | 0.24 | 0.086 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.086 0.071 DBMET00414 | DBMET00414 | |
| 0.008 | 0.23 | 0.041 | DNA gyrase subunit B inhibitor | 0.041 0.022 DBMET00414 | DBMET00414 | |
| 0.029 | 0.274 | 0.119 | MAP-kinase-activated kinase inhibitor | 0.119 0.026 DBMET00414 | DBMET00414 | |
| 0.058 | 0.321 | 0.171 | Antimitotic | 0.171 0.103 DBMET00414 | DBMET00414 | |
| 0.021 | 0.286 | 0.072 | Acetylcholine nicotinic agonist | 0.072 0.068 DBMET00414 | DBMET00414 | |
| 0.034 | 0.325 | 0.138 | DNA directed RNA polymerase inhibitor | 0.138 0.028 DBMET00414 | DBMET00414 | |
| 0.004 | 0.325 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.007 DBMET00414 | DBMET00414 | |
| 0.017 | 0.368 | 0.104 | MAP-kinase-activated kinase 2 inhibitor | 0.104 0.026 DBMET00414 | DBMET00414 | |
| 0.009 | 0.394 | 0.092 | Phosphodiesterase VII inhibitor | 0.092 0.017 DBMET00414 | DBMET00414 | |
| 0.051 | 0.496 | 0.14 | Growth hormone agonist | 0.14 0.095 DBMET00414 | DBMET00414 | |
| 0.009 | 0.479 | 0.061 | HIV-1 reverse transcriptase inhibitor | 0.061 0.058 DBMET00414 | DBMET00414 | |
| 0.038 | 0.523 | 0.252 | Cardiotonic | 0.252 0.081 DBMET00414 | DBMET00414 | |
| 0.009 | 0.578 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.024 DBMET00414 | DBMET00414 | |
| 0.008 | 0.591 | 0.085 | DNA gyrase inhibitor | 0.085 0.023 DBMET00414 | DBMET00414 | |
| 0.071 | 0.698 | 0.172 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET00414 | DBMET00414 | |
| 0.009 | 0.671 | 0.057 | Phosphodiesterase 7A inhibitor | 0.057 0.027 DBMET00414 | DBMET00414 | |
| 0.03 | 0.822 | 0.3 | Caspase 3 stimulant | 0.3 0.079 DBMET00414 | DBMET00414 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |